Abacus Global Management, Inc. (ABX)

Mixed: strong revenue growth and improving cash generation, but valuation and business-model complexity keep uncertainty elevated. Trailing profitability is solid (gross margin 68.55%, net margin 10.55%) and free cash flow has turned positive (FCF yield 9.75%). Recent SEC filings indicate no going-concern language and covenant compliance, yet key risks remain around life-policy valuation assumptions, competition for policies, and regulatory/legal scrutiny; leverage (net debt/EBITDA 3.17) is manageable but worth watching.

The dominant near-term signal is a fresh 10%-owner/insider selling cluster driving a determinate sentiment deterioration (baseline +0.35 → in-window −0.20) and a 6% down session with shares below moving averages; the only bullish element is the open-ended Coventry litigation (TBD, no near-term trigger). Moderate red-flag caps applied for the sharp deterioration with no rewarded bullish catalyst, court-docket-confirmed material litigation (Ritz v. Abacus), and conflicting catalyst signals — a weak, bearish-tilted setup.

ABX ($9.21) closed below its SMA20 (9.55) and SMA50 (9.96) and under EMA9/EMA21 after a five-session slide from 9.62, but held just above the SMA200 (9.11) — today's low 9.141 tagged that support and the stock closed 0.7% above it. Momentum is negative: MACD -0.11 with the histogram just rolling below zero, RSI14 41.36 weak-neutral, and ADX14 8.15 confirms no directional trend strength. Williams %R -91.68 is deeply oversold at the 200-day support zone, which argues for a possible reflex bounce, not a trend trade. ATR14 0.38 (4.13% of price) is adequate range, but the tape is too thin to trade: 20-day average dollar volume is $3.85M, below the $5M floor. Oversold-bounce chart at major support; no tradeable setup.